Skip to search formSkip to main contentSkip to account menu

cyclovirobuxine D

Known as: 9,19-Cyclopregnan-16-ol, 4,4,14-trimethyl-3,20-bis(methylamino)-, (3beta,5alpha,16alpha,20S)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
OBJECTIVE To study the drug releasing properties of Cyclovirobuxine D matrix-type patch. METHOD To prepare Cyclovirobuxine D… 
2008
2008
For many years, alkylation of 1,2-aminoalcohols was usually performed in high yield by catalytic hydrogenation of oxazolidine… 
2004
2004
AIM To determine the effects of cyclovirobuxine D (CD) on intracellular Ca2+ mobilization and L-type Ca2+ current (I(Ca-L)) in… 
2004
2004
AIM To search for new compounds for the treatment of cardiovascular diseases by structural modification of cyclovirobuxine D… 
1997
1997
The present study was undertaken in anesthetized pigs to determine the primary effects of cyclovirobuxine D [corrected] given… 
1981
1981
Cyclovirobuxine D (CVB), an active principle of Buxus microphylla var. sinica, has some therapeutic effect on cardiac arrhythmia…